Despite Safety Concerns, FDA Approves Moderna’s mRNA Flu Shot

On Aug. 5, 2026, the U.S. Food and Drug Administration (FDA) approved Moderna’s seasonal flu shot, mFLUSIVA (mRNA-1010), making it the first messenger RNA platform for seasonal influenza in the United States. The decision permits health care providers to use mRNA technology for annual influenza vaccination in eligible age groups.1 FDA regulators approved mFLUSIVA to […]
Live Experimental Pneumonic Plague Vaccines Being Developed After Repeated Attempts

University of Texas Medical Branch (UTMB) researchers have developed live attenuated experimental pneumonic plague vaccines that, according to a July 28, 2026 press release, fully protected mice in a preclinical study. The findings were published in Science Translational Medicine and, according to UTMB researchers, “challenge decades of assumptions about how immunity to plague works and […]
Oral Vaccine Being Developed for Invasive Bacterial Diarrhea

Researchers are taking steps toward developing an live attenuated oral vaccine aimed at preventing invasive bacterial diarrhea caused by the Shigella bacteria.1 The Shigella bacteria can cause shigellosis—an intestinal infection characterized by diarrhea, fever and stomach cramps. It is one of four highly contagious bacteria that infects tens of millions of people around the world.2 […]
Meningococcal B Vaccine Fails to Protect Against Gonorrhea

A new randomized controlled trial (RCT) published in the New England Journal of Medicine (NEJM) has found that the Meningitis B vaccine does not prevent gonorrhea infections despite a year-long mass vaccination campaign targeting at-risk men in the United Kingdom. After gonorrhea cases exceeded the highest levels ever recorded, the U.K.’s National Health Service (NHS) […]
Oncologist Calls for Banning COVID-19 Shots, as Congress Debates Whether They Cause or Accelerate Cancer

British oncologist and immunologist Angus Dalgleish, MD called for a ban of COVID-19 shots in testimony during a U.S. Senate hearing on COVID shot safety on June 3, 2026, citing an observed “marked increase in unexpected cancers among boosted patients.” Heard by the Senate Permanent Subcommittee on Investigations, the subcommittee convened to discuss whether mRNA […]
CDC Just Awarded Pfizer $1.2 Billion for COVID-19 Shots

U.S. federal procurement records published in June 2026 show that the U.S. Centers for Disease Control and Prevention (CDC) awarded Pfizer more than $1.24 billion in contracts for adult and pediatric mRNA COVID-19 shots for fiscal years 2026 and 2027. The contracts, which were published on SAM.gov and contained more money allocated for pediatric COVID […]
